IRIS
MORONCINI, Gianluca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.325
EU - Europa 2.895
AS - Asia 1.278
SA - Sud America 267
AF - Africa 91
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 8.868
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.280
IT - Italia 686
UA - Ucraina 406
RU - Federazione Russa 372
SG - Singapore 358
HK - Hong Kong 317
SE - Svezia 306
IE - Irlanda 299
DE - Germania 284
CN - Cina 270
BR - Brasile 247
TR - Turchia 167
DK - Danimarca 149
FI - Finlandia 109
GB - Regno Unito 86
KR - Corea 78
FR - Francia 74
CI - Costa d'Avorio 59
AT - Austria 29
NL - Olanda 29
IN - India 26
MA - Marocco 25
CA - Canada 24
BE - Belgio 16
MX - Messico 12
IL - Israele 9
JP - Giappone 9
PL - Polonia 8
RS - Serbia 7
AU - Australia 6
AR - Argentina 5
EE - Estonia 5
EU - Europa 5
PK - Pakistan 5
RO - Romania 5
BD - Bangladesh 4
CZ - Repubblica Ceca 4
ES - Italia 4
TW - Taiwan 4
VE - Venezuela 4
ZA - Sudafrica 4
CL - Cile 3
IQ - Iraq 3
MY - Malesia 3
NI - Nicaragua 3
NO - Norvegia 3
PH - Filippine 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
CO - Colombia 2
JO - Giordania 2
KW - Kuwait 2
LU - Lussemburgo 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
UZ - Uzbekistan 2
YE - Yemen 2
BO - Bolivia 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
ID - Indonesia 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
SI - Slovenia 1
TN - Tunisia 1
VN - Vietnam 1
Totale 8.868
Salva come PNG Salva come JPEG
Città #
Chandler 621
Jacksonville 426
Fairfield 334
Hong Kong 314
Dublin 294
Boardman 286
Ashburn 272
Des Moines 262
Singapore 191
Wilmington 186
Woodbridge 155
Centro 149
New York 144
Houston 142
Seattle 127
Ann Arbor 115
Lawrence 108
Princeton 108
San Mateo 92
Moscow 82
Cambridge 80
Ancona 67
Abidjan 59
The Dalles 59
Redmond 45
Turin 39
Nuremberg 37
Beijing 36
San Diego 35
Los Angeles 33
Munich 31
Marche 30
Tolentino 30
Shanghai 27
London 24
Washington 23
São Paulo 22
Turku 20
Guangzhou 19
Helsinki 17
Jesi 17
Milan 17
Wuhan 15
Pune 14
Brussels 13
Dallas 13
Jiaxing 12
Vienna 12
Falls Church 11
Kilburn 11
Rio de Janeiro 10
Chicago 9
Mexico City 9
Ottawa 9
Izmir 8
Jinhua 8
Porto Alegre 8
Belgrade 7
Belo Horizonte 7
Macerata 7
Norwalk 7
Rome 7
Yiwu 7
Amsterdam 6
Aversa 6
Monte San Pietrangeli 6
Perugia 6
Shenzhen 6
Southwark 6
Tokyo 6
Visakhapatnam 6
West Jordan 6
Ascoli Piceno 5
Chiaravalle 5
Falconara Marittima 5
Jerusalem 5
Nürnberg 5
Osimo 5
Santa Clara 5
Squinzano 5
Auburn Hills 4
Brasília 4
Brisbane 4
Brooklyn 4
Bucharest 4
Fermo 4
Genoa 4
Hangzhou 4
Indaiatuba 4
Montelupone 4
Montreal 4
Naples 4
Scuola 4
Stockholm 4
Toronto 4
Bengaluru 3
Boston 3
Camerino 3
Campinas 3
Changsha 3
Totale 5.548
Salva come PNG Salva come JPEG
Nome #
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease 143
The value of admission Troponin I to predict outcomes in suspected infections in elderly patients admitted in Internal Medicine: results from the SOFA-T collaboration, a multi-center study 141
The first outstanding 50 years of “Università Politecnica delle Marche”: Research achievements in life sciences 134
An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud'€™s phEnomenon (SUNSHINE survey) 129
Preface 126
Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti−Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies 125
Development of the optimal touchscreen interface for patients with scleroderma 118
Epitope specificity determines pathogenicity and detectability of anti-platelet-derived growth factor receptor α autoantibodies in systemic sclerosis 117
Atrial Fibrillation on Patients with Vascular Dementia: A Fundamental Target for Correct Management 116
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies 114
Erratum: Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance [Radiol med, DOI 10.1007/s11547-014-0419-7] 112
Adalimumab modulates angiogenesis in psoriatic skin 110
Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs. 109
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 108
Agonistic anti-PDGF receptor autoantibodies from patients with systemic sclerosis impact human pulmonary artery smooth muscle cells function in vitro 106
Hypothalamic-pituitary-adrenal axis disregulation in PrPC-null mice. 101
Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach 101
B CELL RECEPTOR EDITING IN SCLERODERMA PATIENTS GENERATES PATHOGENIC ANTI-PDGFR AUTOANTIBODIES 99
Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice 99
Biosensor-based Binding Assay for Platelet-Derived Growth Factor Receptor-α Autoantibodies in Human Serum 97
Long lasting biological effects of PDGFR agonistic auto-antibodies in scleroderma 96
Comment on 'Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?' 95
Ha-Ras stabilization mediates pro-fibrotic signals in dermal fibroblasts. 92
A reactive Oxygen species -mediated loop mantains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis 88
Contributions of neuronal prion protein on sleep recovery and stress response following sleep deprivation. 87
MOTIF-GRAFTED HYBRID POLYPEPTIDES AND USES THEREOF 87
Pathogenic autoantibodies in systemic sclerosis 86
SOFA and qSOFA usefulness for in-hospital death prediction of elderly patients admitted for suspected infection in internal medicine 85
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 84
Biologics in inflammatory immune-mediated systemic diseases 83
History and scientific production of clinica medica and clinica ematologica in ancona 83
WIF1, A WNT PATHWAY INHIBITOR, IS SILENCED IN SYSTEMIC SCLEROSIS BY DNA DAMAGE: A MECHANISM LINKING DNA DAMAGE TO WNT AND FIBROSIS 82
Reduced type I collagen gene expression by skin fibroblasts of patients with systemic sclerosis after one treatment course with rituximab 82
Analysis of ATP8B4 F436L missense variant in a large systemic sclerosis cohort 82
Mycophenolate mofetil-induced colitis in a patient with systemic sclerosis 82
Influence of TYK2 in systemic sclerosis susceptibility: A new locus in the IL-12 pathway 80
Low-dose Oral Imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide. A phase II pilot study 80
Detection of typical and atypical bovine spongiform encephalopathy and scrapie prion strains by prion protein motif-grafted antibodies. 80
Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis 79
Agonistic antibodies in systemic sclerosis 78
6 and 12 month outcomes in patients following COVID-19-related hospitalization: a prospective monocentric study 77
SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study 77
PDGF receptor as therapeutic and diagnostic target in systemic sclerosis 76
Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance 76
Downregulation of GPR83 in the hypothalamic preoptic area reduces core body temperature and elevates circulating levels of adiponectin. 76
BIOLOGIC THERAPY IN INFLAMMATORY IMMUNOMEDIATED SYSTEMIC DISEASES: SAFETY PROFILE 76
AUTOIMMUNITY TO PDGFR: A RELEVANT PATHOGENIC LINK IN SSc 74
Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin 74
Delection of typical and atypical bovine spongiform encephalopathy and scraipe prion strains by prion protein motif-grafted antibodies 73
Oxidative stress and the pathogenesis of scleroderma: the Murrell's hypothesis revisited. 73
Autoantibodies against the platelet-derived growth factor receptor in scleroderma: comment on the articles by Classen et al and Loizos et al. 73
Developments in the management of advanced soft-tissue sarcoma –€“ Olaratumab in context 73
Cloning of agonistic autoantibodies specific for the PDGF receptor from the B-cell repertoire of SSc patients 73
Immunohistochemical detection and localization of somatostatin receptor subtypes in prostate tissue from patients with bladder outlet obstruction. 72
Scleroderma-like fibrosis in chronic graft-vs-host disease is sustained by anti-PDGF receptors antibodies 71
Risk prediction of clinical adverse outcomes with machine learning in a cohort of critically ill patients with atrial fibrillation 71
Detection of typical and atypical BSE and scrapie prion strains by prion protein motif-grafted antibodies. 70
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis? 70
Reactivation of Hepatitis B Virus Infection Associated with Anti-Tumor Necrosis Factor-α Therapy 69
Putative functional pathogenic autoantibodies in systemic sclerosis 69
Stimulatory Auto-Antibodies To The PDGF Receptor As Pathology Marker And Therapeutic Target 68
Update of EULAR recommendations for the treatment of systemic sclerosis 68
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways 67
Isolation and cloning of stimulatory anti-PDGF receptor auto-antibodies from the immunological repertoire of patients with systemic sclerosis 66
Lack of interleukin-13 receptor α1 delays the loss of dopaminergic neurons during chronic stress 66
The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patients 64
CLONING OF AGONISTIC AUTOANTIBODIES SPECIFIC FOR THE PDGF RECEPTOR FROM THE B CELL REPERTOIRE OF PATIENTSAFFECTED BY SYSTEMIC SCLEROSIS 64
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 64
Improving the EHMRG Prognostic Evaluation of Acute Heart Failure with TAPSE/PASp: A Sequential Approach 64
Role of viral infections in the etiopathogenesis of systemic sclerosis 63
Efficacy and safety of intravenous and subcutaneous tocilizumab in a cohort of patients affected by rheumatoid arthritis in real-life 61
Epitopes of the human PDGF receptor able to bind human auto-antibodies, antibodies and uses thereof 60
NADPH oxidase, oxidative stress and fibrosis in systemic sclerosis 60
Echocardiographic predictors of mortality in intermediate-risk pulmonary embolism 60
Development of A Solid Phase Binding Assay For Detection of Conformational Anti-PDGFR Autoantibodies In the Serum of Patients Affected By Scleroderma 59
Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc 59
Isolation and cloning of stimulatory anti-PDGF receptor auto-antibodies from the immunological repertoire of patients with systemic sclerosis 58
Development of a conformation-dependent immunoassay for the diagnosis of systemic sclerosis 58
Impact of atrial fibrillation in critically ill patients admitted to a stepdown unit 56
DETECTION OF STIMULATORY ANTI-PDGF RECEPTOR AUTOANTIBODIES BY BIOASSAYS BASED ON DIFFERENT CELL LINES 56
Early administration of tofacitinib in COVID-19 pneumonitis: An open randomised controlled trial 55
A machine learning analysis to predict the response to intravenous and subcutaneous immunoglobulin in inflammatory myopathies. A proposal for a future multi-omics approach in autoimmune diseases 55
Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets 53
Reply 53
Platelet-activating factor acetylhydrolase: A biomarker in Hymenoptera venom allergy? 53
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 52
Common Variable Immunodeficiency in Elderly Patients: A Long-Term Clinical Experience 52
New insights into the role of oxidative stress in scleroderma fibrosis. 51
Treatment With Rituximab Reduces Activation Of Scleroderma Dermal Fibroblasts 51
Oxidative DNA damage induces the ATM-mediated transcriptional suppressionof the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis 51
Letter to the Editor. Reply to Magalon J et al. (CT-1406) 51
Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches 51
Pre-scleroderma and new opportunities for preventive medicine 50
Development of a conformation-dependent immunoassay for the diagnosis of systemic sclerosis 50
Current take on systemic sclerosis patients’ vaccination recommendations 50
The proinflammatory cytokine interleukin 18 regulates feeding by acting on the bed nucleus of the stria terminalis 49
Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients 49
PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis 49
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. 48
Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease 48
Totale 7.721
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.676
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.676
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020141 0 0 0 0 0 0 0 0 0 0 27 114
2020/20211.469 67 141 176 3 185 98 177 104 162 129 152 75
2021/2022865 44 190 23 29 22 43 20 53 83 57 125 176
2022/20231.821 148 189 128 162 113 403 9 101 382 24 122 40
2023/20241.153 163 38 66 138 167 233 21 51 11 82 57 126
2024/20252.405 319 259 75 48 128 119 345 128 585 190 209 0
Totale 9.192